The Reason to Visit an Inherited Neuropathy Consortium Site

by Anthony Palmeri | Oct 19, 2026

Using AI to Build Better Outcome Measurements

by Anthony Palmeri | Oct 19, 2026

FDA and CMT: How the FDA Thinks About CMT Evaluation

by Anthony Palmeri | Oct 19, 2026

How regulators evaluate potential CMT therapies.

How I Chose to Participate in a Clinical Trial

by Anthony Palmeri | Oct 19, 2026

A firsthand account from people who have been through a CMT trial.

What to Expect in a Clinical Trial

by Anthony Palmeri | Oct 19, 2026

Screening, study visits and what a typical trial day looks like, explained step by step.